(Q33495995)

27 July 2017

Use of enoxaparin in patients with heparin-induced thrombocytopenia syndrome (English)

1 reference

heparin-induced thrombocytopenia

27 July 2017

1 reference

1 reference

Slocum MM

1

1 reference

27 July 2017

Adams JG Jr

2

1 reference

27 July 2017

Teel R

3

1 reference

27 July 2017

Spadone DP

4

1 reference

27 July 2017

Silver D

5

1 reference

27 July 2017

1 May 1996

1 reference

Journal of Vascular Surgery

27 July 2017

1 reference

27 July 2017

23

1 reference

27 July 2017

5

1 reference

27 July 2017

839-843

1 reference

Heparin-induced thrombocytopenia, thrombosis, and hemorrhage

27 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2970246-X

7 January 2021

Heparin-induced thrombocytopenia. What is its real frequency?

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2970246-X

7 January 2021

The use of a low molecular weight heparinoid (Org 10172) for extracorporeal procedures in patients with heparin dependent thrombocytopenia and thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2970246-X

7 January 2021

Use of low-molecular-weight heparin in heparin-induced thrombocytopenia with thrombotic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2970246-X

7 January 2021

Treatment of heparin-induced thrombocytopenia with thrombosis by new heparinoid

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2970246-X

7 January 2021

Pregnancy associated with lupus anticoagulant and heparin induced thrombocytopenia: management with a low molecular weight heparinoid.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2970246-X

7 January 2021

Treatment of heparin-associated thrombocytopenia and thrombosis with low molecular weight heparin (CY 216).

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2970246-X

7 January 2021

Heparin-Induced Thrombocytopenia With Thrombosis and Hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2970246-X

7 January 2021

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2970246-X

7 January 2021

Do patients with the heparin-induced thrombocytopenia syndrome have heparin-specific antibodies?

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2970246-X

7 January 2021

Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2970246-X

7 January 2021

Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2970246-X

7 January 2021

In vitro studies of the interaction of heparin, low molecular weight heparin and heparinoids with platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2970246-X

7 January 2021

10.1016/S0741-5214(96)70246-X

Identifiers

DOI

1 reference

27 July 2017

1 reference